Description: 1995 Valuation Actuary Symposium. In this session about small company issues, the panel discussed the role of actuaries in strategic alliances, the cost of regulatory compliance, and cash-flow-testing software.

Description: This presentation is from session number 2, presented at the 1999 Valuation Actuary Symposium, held September 23-24 in Los Angeles. The panelists discuss current statutory valuation issues pertaining to life and annuity products. They provide updates on the Unified Valuation Law [UVL] Task Force, equity-indexed products [including NAIC actuarial guidelines ZZZ and ZZZZ], NAIC actuarial guidelines XXXIII and XXXIV, variable annuity guaranteed living benefits VAGLB, the NAIC Model Regulation for Group Annuity Separate Accounts, Actuarial Opinion and Memorandum Regulation [AOMR] revisions, and other current topics.

Description: From a session at the 2000 Valuation Actuary Symposium held in Washington DC, September 14-15, 2000 This session talks about the issues that smaller companies deal with. Topics included: • Section 7 opinions —changing cash-flow testing requirements • C-3 risk-based capital requirements and methodologies • Setting and resetting X factors for Regulation XXX • Developing internal management systems • Regulatory update • Using outside consultants

Description: From the 1986 Valuation Actuary Symposium, held in Washington DC in October 1986 Discussion of cash flow testing to assess level of C-1,C-2, and C-3 risk. Also, update on regulatory and legislative issues in Canada pertaining to the Valuation Actuary, reserves, and risk based capital

Description: This session from the 1992 Valuation Actuary Symposium focuses on Risk-Based Capital issues and the important points concerning A.M. Best's view of leverage and capital adequacy in the review process.

Description: This session from the 1993 Valuation Actuary Symposium looks at an overview of developments in 1993 including a regulator's viewpoint of various valuation actuary issues, an update on the valuation actuary and health insurance, current developments in reinsurance that should be considered in the valuation process and a sample actuarial opinion and memorandum.

Description: 1996 Valuation Actuary Symposium. Questions asked and answered included: 1. What do regulators expect or want as far as asset adequacy analysis for shorter-term liabilities such as IBNR? 2. What responsibility does the appointed actuary have in verifying reserves for reinsured business? 3. If the assets for the market value adjusted annuity are held in a separate account and valued at market, what rates should be used to present value the projected guaranteed benefits? 4. May a company perform the cash-flow testing based on the low level of reserves held in the domiciliary state rather than the higher reserve actually held in the state with the special state in filing? 5. Have there been any situations where an opining valuation actuary has been held personally responsible?

Description: 1998 Valuation Actuary Symposium. The panelists discussed product design of Equity Indexed products, interest crediting strategies, investment risks, hedging issues, and internal controls and risk management for companies getting started in the derivatives market.

Description: 1998 Valuation Actuary Symposium. Dynamic Financial Condition Analysis is analysis and sensitivity testing and stress testing. Stated another way it is measuring the ability of a company to support future operations. The panelists provided an update on recent Society research that has been done and examples in practice.

Description: Discussion of leading edge companies. Topics included: 1. How they got there 2. Lessons to be learned 3. Financial reporting issues faced by actuaries and others involved with companies that have failed or are close to statutory insolvency 4. Turning it around- strategies for future success.